SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Thursday reported a loss of $37.1 million in its third quarter. On a per-share basis, the San Francisco-based company said it ...
Nektar Therapeutics today reported financial results for the third quarter ended September 30, 2024. Cash and investments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback